🎗️ OncologySolution (pyelocalyceal instillation)
Jelmyto
mitomycin
A mitomycin-based alkylating agent indicated for adults with low-grade upper tract urothelial cancer (LG-UTUC).
Form
Solution (pyelocalyceal instillation)
Uses
2
Side effects
3
Category
Oncology
01
What is Jelmyto used for?
- Treatment of adults with low-grade upper tract urothelial cancer (LG-UTUC).
- Administered directly into the renal collecting system via ureteral catheter or nephrostomy tube.
02
mitomycin side effects
Common side effects of mitomycin include:
Ureteric obstruction, including hydronephrosis and obstructive uropathy.
Flank pain, nausea, and hematuria have been reported.
Local adverse reactions at the instillation site.
CommonModerateLess common
03
mitomycin warnings & precautions
- Ureteric obstruction may occur; monitor patients for signs and symptoms and manage promptly.
- Can cause fetal harm; advise patients of reproductive potential to use contraception.
- Contains mitomycin, a cytotoxic drug; use safe handling and disposal procedures.
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Jelmyto in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.